I would say it is only human nature for patients to then want the best in class and ask their doctors for it. Novo Nordisk said it was aware of the SURMOUNT-5 trial, adding that it had no plans for its own study to directly compare Wegovy with Zepbound
To view a copy of this license, visit About this article Cite this article Zhang, Z., Jiao, Y., Wang, Y
Over a mean follow-up period of 39.8 months, semaglutide demonstrated superiority over placebo in reducing the composite endpoint of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among overweight or obese patients with established cardiovascular disease, but without diabetes
Dose increase speed GLP-1 treatment begins with a low dose that increases gradually to give your body time to adjust
Storage and stability data are less well-established
Within the Golgi the proinsulin protein is folded into its native structure which is stabilized by intrachain disulfide bonds